Citation: As. Hollister et al., SUSTAINED-RELEASE ZIDOVUDINE THERAPY REDUCES THE FREQUENCY OF RESISTANCE DEVELOPMENT IN HIV-INFECTED PATIENTS, Journal of investigative medicine, 44(3), 1996, pp. 249-249
Citation: As. Hollister et al., SUSTAINED-RELEASE ZIDOVUDINE THERAPY REDUCES THE FREQUENCY OF RESISTANCE DEVELOPMENT IN HIV-INFECTED PATIENTS, Journal of investigative medicine, 44(1), 1996, pp. 126-126
Citation: Jm. Dunn et As. Hollister, ORAL BIOAVAILABILITY OF HEPARIN USING A NOVEL DELIVERY SYSTEM, Current therapeutic research, 56(8), 1995, pp. 738-745
Citation: H. Panayiotou et al., ATRIAL WALL TENSION CHANGES AND THE RELEASE OF ATRIAL-NATRIURETIC-FACTOR ON RELIEF OF CARDIAC-TAMPONADE, The American heart journal, 129(5), 1995, pp. 960-967
Citation: Ap. Aboaf et al., DELAYED SUPPRESSION OF PLASMA-RENIN ACTIVITY AND ALDOSTERONE LEVELS DURING SODIUM RETENTION IN ESSENTIAL-HYPERTENSION, Clinical research, 42(1), 1994, pp. 10000082-10000082
Citation: As. Hollister et Ha. Frazer, THE EFFECTS OF A HIGH-FAT MEAL ON THE SERUM PHARMACOKINETICS OF SUSTAINED-RELEASE ZIDOVUDINE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 193-193
Citation: As. Hollister, ZIDOVUDINE PHARMACOKINETICS AND INTRALYMPHOCYTIC CONCENTRATIONS AFTERADMINISTRATION OF CONVENTIONAL AND SUSTAINED-RELEASE PREPARATIONS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 194-194